Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hikma Pharmaceuticals PLC

HIK
Current price
1 809 GBX -22.05 GBX (-1.20%)
Last closed 1 826 GBX
ISIN GB00B0LCW083
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange London Exchange
Capitalization 4 085 838 375 GBX
Yield for 12 month +3.37 %
1Y
3Y
5Y
10Y
15Y
HIK
21.11.2021 - 28.11.2021

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom. Address: 1 New Burlington Place, London, United Kingdom, W1S 2HR

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

179 326.96 GBX

P/E ratio

27.8333

Dividend Yield

4.39 %

Current Year

+226 285 787 500 GBX

Last Year

+198 108 287 700 GBX

Current Quarter

+123 493 008 900 GBX

Last Quarter

+113 969 328 800 GBX

Current Year

+109 404 259 000 GBX

Last Year

+99 565 746 500 GBX

Current Quarter

+59 503 323 600 GBX

Last Quarter

+54 466 005 200 GBX

Key Figures HIK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 846 031 557 GBX
Operating Margin TTM 25.62 %
PE Ratio 27.8333
Return On Assets TTM 9.4 %
PEG Ratio 2.3791
Return On Equity TTM 12.88 %
Wall Street Target Price 179 326.96 GBX
Revenue TTM 3 024 262 029 GBX
Book Value 10.33 GBX
Revenue Per Share TTM
Dividend Share 0.79 GBX
Quarterly Revenue Growth YOY 10 %
Dividend Yield 4.39 %
Gross Profit TTM 1 268 044 928 GBX
Earnings per share 0.66 GBX
Diluted Eps TTM 0.66 GBX
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 71.2 %
Profit Margin 9.45 %

Dividend Analytics HIK

Dividend growth over 5 years

77 %

Continuous growth

7 years

Payout Ratio 5 years average

54 %

Dividend History HIK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.62
Ex Dividend Date 15.08.2024
Forward Annual Dividend Yield 3.36 %
Last Split Factor 1:1
Payout Ratio 72.75 %
Last Split Date 04.09.2013
Dividend Date

Stock Valuation HIK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 27.8333
Forward PE 11.8203
Enterprise Value Revenue 2.1689
Price Sales TTM 1.351
Enterprise Value EBITDA 11.2964
Price Book MRQ 2.3993

Financials HIK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HIK

For 52 weeks

1 648.09 GBX 2 119.09 GBX
50 Day MA 1 922.46 GBX
Shares Short Prior Month
200 Day MA 1 925.36 GBX
Short Ratio
Shares Short
Short Percent